581 related articles for article (PubMed ID: 16316970)
41. Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats.
Tiebosch IA; Crielaard BJ; Bouts MJ; Zwartbol R; Salas-Perdomo A; Lammers T; Planas AM; Storm G; Dijkhuizen RM
J Neurochem; 2012 Nov; 123 Suppl 2():65-74. PubMed ID: 23050644
[TBL] [Abstract][Full Text] [Related]
42. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
[TBL] [Abstract][Full Text] [Related]
43. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
Jin R; Xiao AY; Liu S; Wang M; Li G
Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
[TBL] [Abstract][Full Text] [Related]
44. Infarct prediction and treatment assessment with MRI-based algorithms in experimental stroke models.
Wu O; Sumii T; Asahi M; Sasamata M; Ostergaard L; Rosen BR; Lo EH; Dijkhuizen RM
J Cereb Blood Flow Metab; 2007 Jan; 27(1):196-204. PubMed ID: 16685257
[TBL] [Abstract][Full Text] [Related]
45. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment.
Yamada M; Huang Z; Dalkara T; Endres M; Laufs U; Waeber C; Huang PL; Liao JK; Moskowitz MA
J Cereb Blood Flow Metab; 2000 Apr; 20(4):709-17. PubMed ID: 10779015
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
Lapchak PA
Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
[TBL] [Abstract][Full Text] [Related]
47. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
[TBL] [Abstract][Full Text] [Related]
48. MRI evaluation of treatment of embolic stroke in rat with intra-arterial and intravenous rt-PA.
Jiang Q; Zhang ZG; Zhang L; Ding GL; Li L; Ewing JR; Lu M; Whitton P; Hu J; Li QJ; Zhang RL; Chopp M
J Neurol Sci; 2004 Sep; 224(1-2):57-67. PubMed ID: 15450772
[TBL] [Abstract][Full Text] [Related]
49. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
[TBL] [Abstract][Full Text] [Related]
50. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
51. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
Yi JS; Kim YH; Koh JY
Exp Neurol; 2004 Oct; 189(2):354-60. PubMed ID: 15380485
[TBL] [Abstract][Full Text] [Related]
52. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
53. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
[TBL] [Abstract][Full Text] [Related]
54. Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats.
Zhang L; Chopp M; Jia L; Cui Y; Lu M; Zhang ZG
J Cereb Blood Flow Metab; 2009 Nov; 29(11):1816-24. PubMed ID: 19638998
[TBL] [Abstract][Full Text] [Related]
55. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T
J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117
[TBL] [Abstract][Full Text] [Related]
56. Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a neuroprotective strategy.
Ribó M; Molina C; Alvarez B; Dinia L; Alvarez-Sabin J; Matas M
J Neuroimaging; 2009 Apr; 19(2):188-90. PubMed ID: 18800999
[TBL] [Abstract][Full Text] [Related]
57. Atorvastatin enhances hypothermia-induced neuroprotection after stroke.
Lee SH; Kim YH; Kim YJ; Yoon BW
J Neurol Sci; 2008 Dec; 275(1-2):64-8. PubMed ID: 18768189
[TBL] [Abstract][Full Text] [Related]
58. Acute changes of coagulation and fibrinolysis parameters after experimental thromboembolic stroke and thrombolytic therapy.
Stehling F; Weber R; Ozcelik A; Bröcker M; Volbracht L; Diener HC; Busch E
Neurosci Lett; 2008 Aug; 441(1):39-43. PubMed ID: 18597942
[TBL] [Abstract][Full Text] [Related]
59. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbits.
Lapchak PA; Han MK
Brain Res; 2009 Dec; 1303():144-50. PubMed ID: 19781532
[TBL] [Abstract][Full Text] [Related]
60. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
You YP
J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
